CloudMile: Supercharging Malaysia’s Digital Economy on Three Fronts
AI and cloud tech leader CloudMile is empowering local organizations, leveraging Google infrastructure and nurturing…
3 years ago
Wire Stories
CloudMile: Supercharging Malaysia’s Digital Economy on Three Fronts
AI and cloud tech leader CloudMile is empowering local organizations, leveraging Google infrastructure and nurturing…
3 years ago
CloudMile: Supercharging Malaysia’s Digital Economy on Three Fronts
AI and cloud tech leader CloudMile is empowering local organizations, leveraging Google infrastructure and nurturing…
3 years ago
Genius Group Ltd. Announces 60.68% Revenue Growth for the Nine Months Ended September 30, 2022 and Expansion of Gross Margin on a Pro Forma Basis to 47.33%
SINGAPORE--(BUSINESS WIRE)--$GNS #GNS--Genius Group Limited (“Genius Group” or the “Company”) (NYSE American: GNS), a leading…
3 years ago
Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema
Approval of First Minimally Invasive Treatment Option in Japan that Helps Patients with Advanced Disease…
3 years ago
Genius Group Ltd. Announces 60.68% Revenue Growth for the Nine Months Ended September 30, 2022 and Expansion of Gross Margin on a Pro Forma Basis to 47.33%
SINGAPORE--(BUSINESS WIRE)--$GNS #GNS--Genius Group Limited (“Genius Group” or the “Company”) (NYSE American: GNS), a leading…
3 years ago
Genius Group Ltd. Announces 60.68% Revenue Growth for the Nine Months Ended September 30, 2022 and Expansion of Gross Margin on a Pro Forma Basis to 47.33%
SINGAPORE--(BUSINESS WIRE)--$GNS #GNS--Genius Group Limited (“Genius Group” or the “Company”) (NYSE American: GNS), a leading…
3 years ago
Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema
Approval of First Minimally Invasive Treatment Option in Japan that Helps Patients with Advanced Disease…
3 years ago
Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema
Approval of First Minimally Invasive Treatment Option in Japan that Helps Patients with Advanced Disease…
3 years ago
3D Emphasizes the Need for Substantial Board Change at Fuji Soft
Believes Fuji Soft’s Recent Commitments to Address the Company’s Issues Are a Direct Response to…
3 years ago